secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2021-07-13T23:59:59+00:00
Accession:  0001384101-21-000120
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte signs definitive agreement to acquire HalioDx for up to €113M in stock
-------------------------------------------------------------------------------

- Entered into Securities Purchase and Contribution Agreement on July 13, 2021.
- Consideration includes up to €113M in Veracyte common stock, with option to substitute cash.
- Closing subject to customary conditions, including French foreign investment authorization.
- Stock to be issued in private placement exempt from registration under Section 4(a)(2) and/or Regulation S.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000138410121000120/0001384101-21-000120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000138410121000120/vcyt-20210713.htm
  HTML page:      https://secwatch.observer/filing/0001384101-21-000120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer